Assembly Biosciences (ASMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -62,152 | -97,634 | -90,751 | -42,809 | -44,261 |
| Depreciation Amortization | 678 | -1,241 | 414 | 219 | 80 |
| Income taxes - deferred | 0 | -774 | 1,099 | -9,050 | -618 |
| Accounts receivable | 2,144 | -944 | -156 | -2,273 | N/A |
| Other Working Capital | -30,309 | -9,527 | -4,205 | 44,284 | 3,753 |
| Other Operating Activity | 26,682 | 26,053 | 28,641 | 11,489 | 6,164 |
| Operating Cash Flow | $-62,957 | $-84,067 | $-64,958 | $1,860 | $-34,882 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -470 | -1,554 | -340 | -865 | -147 |
| Purchase Of Investment | -193,188 | -281,334 | -183,941 | -48,234 | -7,951 |
| Sale Of Investment | 263,478 | 232,570 | 48,884 | 33,457 | 44,294 |
| Other Investing Activity | -1,750 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $68,070 | $-50,318 | $-135,397 | $-15,642 | $36,196 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 7,599 | 135,408 | 155,833 | 67,240 | 153 |
| Other Financing Activity | 0 | 4,238 | 3,960 | 0 | 0 |
| Financing Cash Flow | $7,599 | $139,646 | $159,793 | $67,240 | $153 |
| Beginning Cash Position | 46,732 | 41,471 | 82,033 | 28,575 | 27,108 |
| End Cash Position | 59,444 | 46,732 | 41,471 | 82,033 | 28,575 |
| Net Cash Flow | $12,712 | $5,261 | $-40,562 | $53,458 | $1,467 |
| Free Cash Flow | |||||
| Operating Cash Flow | -62,957 | -84,067 | -64,958 | 1,860 | -34,882 |
| Capital Expenditure | -470 | -1,554 | -340 | -865 | -147 |
| Free Cash Flow | -63,427 | -85,621 | -65,298 | 995 | -35,029 |